Pacer Advisors Inc. Sells 17,053 Shares of Cigna Group $CI

Pacer Advisors Inc. lessened its holdings in Cigna Group (NYSE:CI) by 56.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,179 shares of the health services provider’s stock after selling 17,053 shares during the quarter. Pacer Advisors Inc.’s holdings in Cigna Group were worth $3,515,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in CI. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group in the 4th quarter valued at approximately $25,000. Kemnay Advisory Services Inc. bought a new position in shares of Cigna Group during the 4th quarter worth approximately $29,000. Prosperity Bancshares Inc bought a new stake in Cigna Group in the fourth quarter valued at $29,000. Cedar Mountain Advisors LLC raised its stake in Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after acquiring an additional 68 shares in the last quarter. Finally, Creative Financial Designs Inc. ADV increased its position in shares of Cigna Group by 147.3% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after purchasing an additional 81 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Barclays raised their price target on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Guggenheim lifted their target price on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. UBS Group boosted their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and cut their price target for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $339.45.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 222,213 shares of company stock valued at $64,751,950 over the last three months. Company insiders own 0.60% of the company’s stock.

Cigna Group Trading Up 1.8%

Shares of NYSE CI opened at $275.26 on Friday. The company’s 50 day simple moving average is $285.90 and its 200 day simple moving average is $281.20. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The firm has a market capitalization of $72.73 billion, a P/E ratio of 11.39, a P/E/G ratio of 0.93 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the firm earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts predict that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s payout ratio is 25.82%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.